Table of Contents

• FDA’s BSE Final Rule Published; New Requirements Imposed on Renderers [ARCHIVED]
  by Walt D. Osborne, M.S., J.D., Assistant Editor
• CVM Has Significant Role in Regulating Advertising, Labeling of New Animal Drugs [ARCHIVED]
  by Carmela Stamper, DVM, Communications Staff, with contributions from Thomas Moskal, DVM, Division of Surveillance, Office of Surveillance and Compliance
• FDA Proposes Reauthorization of User Fees for Pioneer Drugs and Authorization of the First-Ever User Fees for Generic Drugs [ARCHIVED]
  by Jon F. Scheid, Editor
• Several Firms, Corporate Executives Indicted in Adulterated Pet Food Case [ARCHIVED]
  by Walt D. Osborne, M.S., J.D., Assistant Editor
• Understanding Genetic Variability in Dogs and Its Potential Role in Drug Development [ARCHIVED]
  by Michele Sharkey, D.V.M.; Marilyn Martinez, Ph.D.; Sanja Modric, D.V.M., Ph.D.; Lisa Troutman, D.V.M., MS; and Lynn Walker, D.V.M.; Office of New Animal Drug Evaluation
• Escherichia Coli O157:H7 Foodborne Illness and the Usefulness of the Critical Path in FDA’s Work to Combat It [ARCHIVED]
  by Richard Arkin, J.D., Assistant Editor
• Regulatory Activities – February 2008 [ARCHIVED]
• Comings and Goings - January / February 2008 [ARCHIVED]
• Approvals for February 2008 [ARCHIVED]